Today: 17 May 2026
Browse Category

AMS:ENX 17 November 2025 - 22 February 2026

Euronext share price up 4% into weekend: week ahead for ENX stock hinges on ECB signals and German Ifo

Euronext share price up 4% into weekend: week ahead for ENX stock hinges on ECB signals and German Ifo

Euronext shares closed Friday at 127.40 euros, up 4%, after reporting Q4 revenue of 456.4 million euros and an 8.9% rise in core profit. The company confirmed a 250 million euro buyback and a proposed 321.5 million euro dividend. Euro zone PMI rose to 51.9 in February. Euronext will migrate Nordic power futures open interest from Nasdaq Clearing on March 14.
22 February 2026
·
Euronext (ENX) Stock Outlook: Share Price Holds Near €126 as Year-End Trading Returns and 2026 Rate-Cut Bets Build

Euronext (ENX) Stock Outlook: Share Price Holds Near €126 as Year-End Trading Returns and 2026 Rate-Cut Bets Build

Euronext closed at €126.60, up 0.40%, with shares rising about 18% over the past year. Trading volume remains thin as year-end holidays keep many investors away. U.S. markets were shut, and Wall Street ended its last session nearly flat. Investors await Fed minutes for signals on interest rates and watch for shifts outside mega-cap tech stocks.
27 December 2025
·
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Today, 18 November 2025: European Stocks Slide as Eutelsat’s €828m Capital Raise, Nexans Buyback and AkzoNobel–Axalta Mega‑Merger Dominate Trade

The Euronext 100 index fell about 1.3% to 1,689–1,690 points by late morning, with the CAC 40 and AEX also down over 1%. Euronext N.V. launched its €250 million share buyback program today, set to run through March 2026. Broader European markets tracked similar declines amid concerns over tech valuations and fewer expected Fed rate cuts.
18 November 2025
·····
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Today: CAC 40 slips as luxury names weigh; Euronext launches 2026 bond tender; Athens bourse bid enters final day — 17 November 2025

European stocks slipped Monday, with the STOXX 600 down 0.2% and Paris’s CAC 40 near 8,150 as luxury and financial shares fell. Airbus outperformed on flydubai order reports. Euronext launched a cash tender for €600 million in 2026 bonds and plans a new issue. Its offer for Hellenic Exchanges–ATHEX closes today.
17 November 2025
····

Stock Market Today

  • S&P Global Stock Approaches Key Support Level with Strong Fundamentals
    May 16, 2026, 10:34 PM EDT. S&P Global (SPGI) shares are trading within a historically significant support zone of $383 to $423, a range that has triggered multiple rebounds averaging 18% gains. The firm surpassed Q1 2026 revenue and earnings estimates, saw 10% and 14% growth respectively, and maintains robust margins with a 40.9% operating margin and 35.3% free cash flow margin. Analysts currently rate SPGI as a 'Strong Buy' with price targets 25-37% above current levels. Despite minor revisions due to foreign exchange impacts, organic growth remains solid at 6-8%. The stock trades at a 25.1 P/E ratio, slightly above the financial sector median but below its historical levels, indicating potential undervaluation amid credit and structural market pressures. Nonetheless, past market shocks caution investors on inherent volatility risks.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop